Why the study?
The Rosendaal method for calculating TTR is tedious and fails to account for out-of-range INR duration, prompting reassessment of the easier-to-calculate FIR method.
Does the Frequency in Range (FIR) method agree with the Time in Therapeutic Range (TTR) method for assessing the quality of warfarin anticoagulation in patients with atrial fibrillation?
Does the Frequency in Range (FIR) method agree with the Time in Therapeutic Range (TTR) method for assessing the quality of warfarin anticoagulation in patients with atrial fibrillation?
Although FIR is easier to calculate and highly correlated with TTR, the two methods are not interchangeable, and TTR should remain the gold standard for assessing warfarin control.
Answers are grounded in this paper and cite their sources.
TTR should remain preferred over FIR for warfarin quality assessment in AF; challenges interchangeability and leaves prospective validation of simpler metrics open.
Background: Atrial fibrillation (AF) is a growing concern worldwide. In order to prevent AF-related adverse vascular events, adequate oral anticoagulation with warfarin is essential. The Rosendaal method has long been used to calculate time in therapeutic range (TTR) in clinical trials to assess the quality of anticoagulation but now suffers dwindling popularity due to its tedious method of calculation and inability to account for the duration spent in an out-of-range international normalized ratio (INR). Frequency in range (FIR) is being reassessed as to its value as it is easier to calculate. Objectives: We aimed to compare FIR and TTR (using the Rosendaal method) as a measure to assess the quality of anticoagulation with warfarin in a cohort of 102 consecutive patients with valvular and non-valvular AF at a tertiary South African hospital. Secondary objectives were to assess the predictive ability of FIR to categorize patients with a TTR ≥ 65% as well as to compare the CHA 2 DS 2 VASc and HASBLED scores with TTRs and FIRs. Methods: We retrospectively analysed the INR values for all patients over a 2-year period and calculated both individual and overall mean TTR and FIR and assessed the agreement between these parameters. Results: The mean overall TTR was 58.1% ± 16% and the mean FIR was 50.8% ± 16.7%. The mean TTR was significantly higher than the mean FIR ( p < 0.0001). At the individual level, FIR was positively correlated with TTR in a linear fashion ( r = 0.93, p < 0.001). However, the Bland–Altman method plot indicated lack of agreement between TTR and FIR, with a bias of 7.4% (95% CI: 6.1%–8.6%) and limits of agreement −4.6% to 19.3%, standard deviation (SD) = 6.1%. A cut-off value of FIR ≥ 53.3% was found to be a good predictor of TTR ≥ 65%. Conclusion: Our study shows that although TTR and FIR are highly correlated with the individual INR levels, they are not equal. The two methods cannot be used interchangeably to assess warfarin control, and TTR should probably remain the gold standard.
No takes yet. Share an insight, caveat, or question.
Parbhoo et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: